Literature DB >> 7847355

Death during the first 90 days of dialysis: a case control study.

I H Khan1, G R Catto, N Edward, A M MacLeod.   

Abstract

Comparison of survival data among centers may be used to assess performance, but may be influenced by the number of patients who die during the first 90 days of renal replacement therapy (RRT). Data published by registries in Europe do not detail these deaths, and US data generally exclude them from analysis for financial reasons. To study factors influencing such deaths we compared 42 patients who died within 90 days of first commencing RRT in one Scottish renal unit (group A) between 1971 and 1992 with 42 age- and sex-matched controls who started RRT over the same period and survived longer (group B). Patients who died within 90 days of RRT ranged in age from 25.3 to 83.7 years and had a mean age of 65.2 (SEM, 1.6; 95% confidence interval, 61.9 to 68.4). The proportion of patients who died during the first 90 days of RRT increased from 2% of all patients treated before 1981 to 12% in subsequent years. Thirty-three patients in group A received emergency dialysis via temporary venous access compared with only nine in group B (P < 0.055). There were more patients in group A with a diagnosis of arteriosclerotic renal artery stenosis (14 v 1) and with a history of smoking (15 v 2) than in group B (P < 0.0005). Median renal or nonrenal follow-up before RRT was 1.1 month in group A and 10.6 months in group B (P < 0.0001). Fewer patients in group A had no coexisting disease (1 v 17; P < 0.0001).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7847355     DOI: 10.1016/0272-6386(95)90009-8

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  19 in total

Review 1.  Recent advances: nephrology.

Authors:  C R Tomson
Journal:  BMJ       Date:  2000-01-08

2.  Early outcomes among those initiating chronic dialysis in the United States.

Authors:  Kevin E Chan; Frank W Maddux; Nina Tolkoff-Rubin; S Ananth Karumanchi; Ravi Thadhani; Raymond M Hakim
Journal:  Clin J Am Soc Nephrol       Date:  2011-09-29       Impact factor: 8.237

Review 3.  Chronic kidney disease and its complications.

Authors:  Robert Thomas; Abbas Kanso; John R Sedor
Journal:  Prim Care       Date:  2008-06       Impact factor: 2.907

Review 4.  Safe and Cost-Effective Peritoneal Dialysis Access by Skilled Nephrologists in Developing Countries.

Authors:  Georgi Abraham; Amit Gupta
Journal:  Perit Dial Int       Date:  2016-11-12       Impact factor: 1.756

5.  A propensity-matched comparison of hard outcomes in children on chronic dialysis.

Authors:  Enrico Vidal; Nicholas C Chesnaye; Fabio Paglialonga; Bruno Minale; Giovanna Leozappa; Mario Giordano; Bruno Gianoglio; Ciro Corrado; Rosa Maria Roperto; Roberto Chimenz; Francesca Mencarelli; Ilse-Maria Ratsch; Luisa Murer; Enrico Verrina
Journal:  Eur J Pediatr       Date:  2017-11-16       Impact factor: 3.183

6.  Peritoneal dialysis can be an option for unplanned chronic dialysis: initial results from a developing country.

Authors:  Dayana Bitencourt Dias; Vanessa Banin; Marcela Lara Mendes; Pasqual Barretti; Daniela Ponce
Journal:  Int Urol Nephrol       Date:  2016-02-20       Impact factor: 2.370

7.  Quality of life at the initiation of maintenance dialysis treatment--a comparison between the SF-36 and the KDQ questionnaires.

Authors:  J F Neto; M B Ferraz; M Cendoroglo; S Draibe; L Yu; R Sesso
Journal:  Qual Life Res       Date:  2000-02       Impact factor: 4.147

8.  Age, Gender and Diabetes as Risk Factors for Early Mortality in Dialysis Patients: A Systematic Review.

Authors:  Adil M Hazara; Sunil Bhandari
Journal:  Clin Med Res       Date:  2021-02-13

9.  Improvement in eGFR in patients with chronic kidney disease attending a nephrology clinic.

Authors:  Hulya Taskapan; Paul Tam; Victoria Au; Stephen Chow; Jason Fung; Gordon Nagai; Janet Roscoe; Paul Ng; Tabo Sikaneta; Robert Ting; Dimitrios G Oreopoulos
Journal:  Int Urol Nephrol       Date:  2008-04-02       Impact factor: 2.370

10.  Roxadustat (FG-4592): Correction of Anemia in Incident Dialysis Patients.

Authors:  Anatole Besarab; Elena Chernyavskaya; Igor Motylev; Evgeny Shutov; Lalathaksha M Kumbar; Konstantin Gurevich; Daniel Tak Mao Chan; Robert Leong; Lona Poole; Ming Zhong; Khalil G Saikali; Marietta Franco; Stefan Hemmerich; Kin-Hung Peony Yu; Thomas B Neff
Journal:  J Am Soc Nephrol       Date:  2015-10-22       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.